Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage (Adults, Pediatrics), By Indication (Cancer Care, Diabetes), By End-user (Hospitals, Home Care), By Sales Channel, By Region, And Segment Forecasts, 20

Enteral Feeding Formulas Market Growth & Trends

The global enteral feeding formulas market size is expected to reach USD 10.52 billion by 2030, registering a CAGR of 5.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is increasingly used for the personalized treatment of diseases, such as cancer and cystic fibrosis. These conditions require special nutrition to avoid any kind of drug interaction.

For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of these digestive enzymes can vary in individuals. Appropriate nutrition is critical for preterm infants, and early nutrition provision could influence better clinical outcomes & growth of the child, including neurodevelopment, decreased risk of Retinopathy of Prematurity (ROP), or prevention of Bronchopulmonary Dysplasia (BPD).

The commitment of NPOs and NGOs to preventing and caring for preterm birth, such as the ‘Every Woman Every Child’ movement of the UN, to advance the global strategy on women’s and children's health, is expected to boost the demand for neonatal & preterm enteral feeding formulas. Growing initiatives to spread awareness regarding the importance of nutrients among the patient population are expected to improve the current market scenario.

According to an article titled ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week, published by ASPEN, around 10 hospitalized patients go undiagnosed every 60 seconds. Hence, this organization established Malnutrition Awareness Week in 2011 to spread awareness regarding malnutrition in hospitalized patients and educate healthcare professionals on the importance of nutrients among patients.

In case of medical necessity, Medicaid must cover enteral nutrition. However, there are no such regulations/mandates on private insurance companies. Moreover, as per the results of a survey conducted by NCBI, there is a huge lack of reimbursement for patients on Home Enteral Nutrition (HEN) and inadequate awareness among stakeholders regarding market opportunities, especially in lower-income countries.

Enteral Feeding Formulas Market Report Highlights

• The standard formula segment led the market with the largest revenue share of 53.7% in 2024. The disease-specific formulas segment is expected to grow at the fastest CAGR during the forecast period.
• The intermittent feeding flow segment accounted for the largest revenue share in 2024. The continuous feeding flow segment is anticipated to grow at the fastest CAGR during the forecast period.
• The adult segment accounted for the largest market revenue share in 2024. The adult segment is also projected to grow at the fastest CAGR during the forecast period.
• The cancer care segment accounted for the largest market revenue share in 2024. The other indications segment is expected to grow at the fastest CAGR over the forecast period.
• The institutional sales segment accounted for the largest market revenue share in 2024. The online sales channel segment is projected to grow at the fastest CAGR over the forecast period.
• The home care segment accounted for the largest market revenue share in 2024. The hospital segment is anticipated to grow at the fastest CAGR during the forecast period.